Literature DB >> 16046723

Long-chain (n-3) polyunsaturated fatty acids are more efficient than alpha-linolenic acid in improving electroretinogram responses of puppies exposed during gestation, lactation, and weaning.

Kimberly M Heinemann1, Mark K Waldron, Karen E Bigley, George E Lees, John E Bauer.   

Abstract

Long-chain PUFAs (LCPUFAs) are essential for proper neural and retinal development in many mammalian species. We investigated puppies born to dogs fed diets containing varying amounts of vegetable and marine (n-3) fatty acids during gestation/lactation. The fatty acid compositions of dogs' milk and puppy plasma phospholipids were evaluated, and electroretinographic responses of the young dogs were determined after they were weaned to the same diets. Dogs' milk fatty acid composition reflected the diets fed during gestation/lactation. The milk of dogs fed a high alpha-linolenic acid (ALA) diet was enriched in ALA but not docosahexaenoic acid (DHA). Puppies fed this ALA-enriched milk accumulated more plasma phospholipid DHA than the low (n-3) fatty acid group. However, this accumulation was less than that obtained in puppies fed preformed DHA during development and suckling (P < 0.05). Electroretinograms (ERGs) of 12-wk-old puppies revealed significantly improved visual performance in dogs fed the highest amounts of (n-3) LCPUFAs (P < 0.05). These puppies demonstrated improved rod response (improved amplitude and implicit time of the a-wave, P < 0.05). Puppies from the low (n-3) fatty acid group exhibited the poorest ERG responses compared with the high-marine or high-vegetable (n-3) groups. A novel parameter devised in this study, the initial intensity at which the a-wave was detectable (i.e., threshold intensity), also demonstrated that retinal response of puppies consuming the (n-3) LCPUFA-containing diets occurred at lower light intensity, thereby exhibiting greater rod sensitivity, than the other diet groups. These findings indicate that preformed dietary (n-3) LCPUFA is more effective than ALA in enriching plasma DHA during perinatal development and results in improved visual performance in developing dogs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046723     DOI: 10.1093/jn/135.8.1960

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

1.  Early and sustained enrichment of serum n-3 long chain polyunsaturated fatty acids in dogs fed a flaxseed supplemented diet.

Authors:  Brent L Dunbar; Karen E Bigley; John E Bauer
Journal:  Lipids       Date:  2009-11-05       Impact factor: 1.880

2.  Comparison of the nutrient composition of commercial dog milk replacers with that of dog milk.

Authors:  Cailin R Heinze; Lisa M Freeman; Camilia R Martin; Michael L Power; Andrea J Fascetti
Journal:  J Am Vet Med Assoc       Date:  2014-06-15       Impact factor: 1.936

3.  Effect of neuroactive nutritional supplementation on body weight and composition in growing puppies.

Authors:  Wei Wang; Melissa Brooks; Cari Gardner; Norton Milgram
Journal:  J Nutr Sci       Date:  2017-11-23

4.  Maternal omega-3 polyunsaturated fatty acid supplementation on offspring hip joint conformation.

Authors:  A M Oberbauer; R Daniels; K Levy; T R Famula; P Mundell; R Kelley
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

5.  Food intake and nutrition during pregnancy, lactation and weaning in the dam and offspring.

Authors:  Emmanuel Fontaine
Journal:  Reprod Domest Anim       Date:  2012-12       Impact factor: 2.005

6.  Antioxidant supplementation increases retinal responses and decreases refractive error changes in dogs.

Authors:  Wei Wang; Jerome Hernandez; Cecil Moore; Janet Jackson; Kristina Narfström
Journal:  J Nutr Sci       Date:  2016-05-10

7.  The Analysis of Docosahexaenoic Acid (DHA) in Dried Dog Food Enriched with an Aurantiochytrium limacinum Biomass: Matrix Extension Validation and Verification of AOAC Method 996.06.

Authors:  Gerald Patrick Dillon; Cathy Cardinall; Jason D Keegan; Alexandros Yiannikouris; Walter Brandl; Colm Anthony Moran
Journal:  J AOAC Int       Date:  2021-03-05       Impact factor: 1.913

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.